Inventor · Ludwigshafen, DE

Franz Emling

12Patents
6h-index
33Co-inventors
62Inventor score

Filing activity: Jun 15, 1987 → Jul 11, 2001

Most-cited inventions

PatentTitleAreaCited byStatus
US5231024A Monoclonal antibodies against human tumor necrosis factor (TNF), and use thereof Human Necessities 243 Expired
US5831002A Antitumor peptides Human Necessities 26 Expired
US6159962A 3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and production and use of the same Human Necessities 21 Expired
US5180811A Proteins having a TNF action comprising TNF-fibromectin fusion protein Emerging Cross-Sectional Technologies 11 Expired
US6222034A 3-substituted pyrido[4',3':4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use Human Necessities 9 Expired
US6414157B1 3-Substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use Human Necessities 6 Expired
US5504189A Peptides, their preparation and use Human Necessities 5 Expired
US6355647B1 3-substituted 3,4,5,7-tetrahedropyrrolo[3′,4′:4,5]thieno-[2,3-d]pyrimidine derivatives, their preparation and use Human Necessities 5 Expired
US6387912B1 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia Human Necessities 4 Expired
US6159981A 3-substituted pyrido [3',4':4,5] Thieno [2,3-d] pyrimidine derivatives, and production and use of the same Human Necessities 2 Expired
US6346622B1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-HT1A, 5HT1B and 5-HT1D) Chemistry; Metallurgy 1 Expired
US5157106A N-terminal deletions of lymphotoxin, their preparation and use Emerging Cross-Sectional Technologies 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.